Colorimetric Activity Assay Kit — Technical Guide (RUO)

Overview

A Colorimetric Activity Assay Kit quantifies an enzyme-catalyzed reaction by converting substrate to a chromophore with absorbance at a defined wavelength (e.g., 405/412/450/540/570/590 nm). Color development is proportional to analyte or enzyme activity and is read on a microplate spectrophotometer. See primers on spectrophotometry and Beer-Lambert law at NCBI Bookshelf (NIH) and NIST:

RUO disclaimer: Procedures below are for Research Use Only and not for diagnostic purposes. Follow institutional biosafety guidance.

Assay principle

  1. Substrate selection: the kit provides a chromogenic substrate that yields a measurable absorbance shift upon enzymatic conversion (e.g., p-nitrophenol at 405 nm, DTNB/TNB at 412 nm, TMB/HRP at 450 nm).

  2. Kinetic or end-point readout:

    • Kinetic: measure ΔAbs/min to calculate initial rate (v₀).

    • End-point: stop reaction chemically, then read at λmax.

  3. Quantification: use a standard curve (chromophore or product) and/or an extinction coefficient (ε) via Beer-Lambert law.
    Useful primers:

AffiASSAY® Myeloperoxidase (MPO) Colorimetric Activity Assay Kit

Kit components (typical)

  • Substrate (lyophilized or solution), Assay Buffer, Enzyme/Developer (when applicable)

  • Positive Control enzyme or analyte

  • Stop Solution (acid/base or chelator)

  • 96-well plate, plate sealers

  • Standard (calibrator) for curve generation
    Chemical handling and waste: EPA hazardous waste basics — https://www.epa.gov/hw (EPA)

Biosafety, PPE, and quality systems

Follow institutional EHS and BSL requirements:

Sample types and preparation

Applicable to cell lysates, tissue homogenates, serum/plasma, or culture supernatants, depending on the targeted enzyme/metabolite. Preparation guidance:

Traceability and reference materials concept: NIST SRMhttps://www.nist.gov/srm (NIST)

Plate layout and controls

Design a plate map with Blank, Standards (A–H), QC-L/M/H, Positive Control, and Samples in duplicates or triplicates. Track drift using Levey–Jennings plots (simple plotting in ImageJ/Fiji):

Step-by-step protocol (generic 96-well format)

  1. Equilibrate all reagents to RT (20–25 °C).

  2. Prepare standards: 2–3-fold serial dilutions covering the expected range (≥7 points + blank).

  3. Prepare samples in assay buffer; pretest multiple dilutions to verify parallelism.

  4. Add 50–100 µL standards/QCs/samples to wells.

  5. Add substrate/developer per IFU; mix gently (no bubbles).

  6. Incubate at the recommended temperature/time. For kinetic assays, read every 30–60 s for 5–10 min.

  7. Stop reaction if end-point format; otherwise continue kinetic reading.

  8. Read absorbance at λmax (e.g., 405/412/450/540/570/590 nm) with a 570–620 nm reference if available.

  9. Analyze with 4PL/5PL curve fitting or linear regression (Beer-Lambert), apply weighting as needed.

Spectrophotometer principles and calibration:

Calculations

A. Standard curve approach

B. Extinction-coefficient approach

Using Beer–Lambert: c=Aε⋅lc=\dfrac{A}{\varepsilon \cdot l}

  • AA: absorbance, ε\varepsilon: extinction coefficient (M⁻¹·cm⁻¹), ll: path length (cm; plate path length is effective and wavelength-dependent).

  • Correct for effective path length in microplates or use path-length correction features.
    Foundational reading:

  • NCBI Bookshelf, spectrophotometry — https://www.ncbi.nlm.nih.gov/books/ (NIH)

Analytical validation (lab-level)

  • Range, LOD, LLOQ: define functional range where total error meets spec; verify LLOQ at %CV ≤ 20% and accuracy 80–120%.

  • Precision: intra-assay (same plate) and inter-assay (days/operators/lots).

  • Accuracy: spike-recovery at low/mid/high; target 80–120%.

  • Parallelism: slopes of serial dilutions vs. standard curve within predefined tolerance.

  • Specificity/interference: evaluate buffer components, detergents, chelators, biotin, hemolysis, lipemia.
    General bioanalytical concepts:

  • FDA bioanalytical method validation (principles) — https://www.fda.gov/media/70858/download (FDA)

  • NLM research reporting — https://www.nlm.nih.gov/NIHbmic/nih_data_sharing.html (NIH/NLM)

Common wavelengths and chemistries (examples)

  • 405 nm: p-nitrophenol (pNP) release (phosphatases, glycosidases).

  • 412 nm: DTNB (Ellman’s; thiol detection producing TNB).

  • 450 nm: HRP/TMB end-point; some oxidase/peroxidase couplings.

  • 540–570 nm: NADH/NADPH linked colorimetric reporters; Griess.

  • 590 nm: MTT-derived or proprietary chromophores.
    See method primers and safety sheets via MIT OCW (https://ocw.mit.edu) and Cornell (https://www.cornell.edu) (EDU).

Troubleshooting

  • Low signal: expired substrate, suboptimal pH/ionic strength, enzyme inactive; verify with Positive Control and fresh substrate.

  • High background: contaminated buffers, inadequate blanks, edge effects; increase washes and use matched matrix blanks.

  • Non-linearity: pipetting drift, wrong timing, substrate depletion; shorten incubation or dilute samples.

  • Inhibition by matrix: dilute samples or add blockers/chelator-free buffers.
    University guides:

  • University of Arizona lab resources — https://www.arizona.edu (EDU)

  • Purdue University teaching labs — https://www.purdue.edu (EDU)

Quality control and documentation

  • Maintain equipment calibration logs (plate reader wavelength/linearity).

  • Track QC-L/M/H across runs with Levey–Jennings.

  • Archive raw ODs, plate maps, analysis files, and versioned SOPs.

  • Comply with institutional data policies: NIH DMShttps://sharing.nih.gov (NIH)
    Health & Human Services policy hub: HHShttps://www.hhs.gov/ (HHS)

Applications (research examples)

  • Enzyme kinetics (Michaelis–Menten, KmK_m, VmaxV_{max}) for oxidases, hydrolases, transferases.

  • Metabolic pathway flux via coupled colorimetric reactions.

  • High-throughput screening in 96/384-well formats.

  • Process development and lot release trending (RUO).
    Explore contextual studies at ClinicalTrials.gov (https://clinicaltrials.gov) and literature on PubMed (https://pubmed.ncbi.nlm.nih.gov/) (NIH).

FAQ (SEO-friendly)

Q1. Kinetic vs end-point—how to choose?
Use kinetic reads for precise activity (initial rate); use end-point when timing and stopping are robust. See NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/ (NIH).

Q2. How many standards are optimal?
≥7 + blank spanning 2–3 logs of range; fit with 4PL/5PL and inspect residuals. See NIDA stats — https://nida.nih.gov/research/statistics (NIH).

Q3. How to address plate path length?
Use instrument path-length correction or calibrate empirically; see NIST photometry — https://www.nist.gov (NIST).

Quick reference links (.gov / .edu)

  1. PubMed (NIH/NLM) — https://pubmed.ncbi.nlm.nih.gov/

  2. MedlinePlus Labs (NIH/NLM) — https://medlineplus.gov/lab-tests/

  3. NIST SRM & metrology — https://www.nist.gov/srm

  4. NIST photometry overview — https://www.nist.gov

  5. FDA bioanalytical validation (concepts) — https://www.fda.gov/media/70858/download

  6. NIH Rigor & Reproducibility — https://www.nih.gov/research-training/rigor-reproducibility

  7. NIH Data Management & Sharing — https://sharing.nih.gov

  8. CDC laboratory biosafety — https://www.cdc.gov/labs/

colorimetric activity assay kit, enzyme activity assay, chromogenic substrate assay, microplate spectrophotometer 96-well, Beer-Lambert law ε extinction coefficient, 4PL 5PL standard curve, initial rate kinetics v0, Km Vmax Michaelis–Menten, spike recovery dilution linearity, intra-assay inter-assay CV, assay validation RUO, path length correction microplate, QC Levey–Jennings, endpoint vs kinetic colorimetric assay, HRP TMB 450 nm, DTNB Ellman’s 412 nm, p-nitrophenol 405 nm.